Diagnosis and management of ventricular tachycardia

scientific article published on June 1, 1992

Diagnosis and management of ventricular tachycardia is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1136/PGMJ.68.800.406
P953full work available at URLhttps://europepmc.org/articles/PMC2399344
https://europepmc.org/articles/PMC2399344?pdf=render
P932PMC publication ID2399344
P698PubMed publication ID1437920

P2093author name stringM. Dancy
P2860cites workReversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranololQ28340406
Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathyQ33158267
Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarctsQ33167437
Significance of the clinical presentation in ventricular tachycardia/fibrillationQ33168061
Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainideQ33169834
Multivariate analysis to simplify the differential diagnosis of broad complex tachycardiaQ33611225
A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complexQ34103324
Wide complex tachycardia: misdiagnosis and outcome after emergent therapyQ34188140
Nonischemic sudden tachyarrhythmic death in atherosclerotic heart diseaseQ37207550
Catheter ablation. Present role and projected impact on health care for patients with cardiac arrhythmiasQ37706885
Clinical management of patients with nonsustained ventricular tachycardia: what do we really know?Q38020524
Values and limitations of programmed stimulation and ambulatory monitoring in the management of ventricular tachycardiaQ38194530
Ventricular tachycardia surgery: a review of the first decade and a suggested contemporary approach.Q38216665
Automatic implantable cardioverter defibrillator. Current statusQ38674185
The role of exercise testing in evaluation of arrhythmiasQ39531531
The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactionsQ40337547
Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular functionQ41186761
The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratioQ42032822
Reproducibility of exercise-induced ventricular arrhythmia in patients undergoing evaluation for malignant ventricular arrhythmiaQ42159984
Misuse of intravenous verapamil in patients with ventricular tachycardiaQ42202153
Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapyQ42214611
Diagnosis of ventricular tachycardia: a clinical algorithmQ42752278
Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)Q44631745
Surgical intervention for drug-resistant ventricular tachycardiaQ44671503
Angiographic findigs and prognostic indicators in patients resuscitated from sudden cardiac deathQ45028238
Recurrence of malignant ventricular arrhythmia after antiarrhythmic drug withdrawalQ45156382
Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac deathQ45195239
The Percutaneous Cardiac Mapping and Ablation Registry: final summary of results.Q45961043
Long-term outcome with the automatic implantable cardioverter-defibrillator.Q45996829
Antiarrhythmic efficacy of solitary beta-adrenergic blockade for patients with sustained ventricular tachyarrhythmiasQ46562014
Respective role of sympathetic tone and of cardiac pauses in the genesis of 62 cases of ventricular fibrillation recorded during Holter monitoring.Q52547959
Misdiagnosis of chronic recurrent ventricular tachycardia.Q52868601
Surgical decisions in the management of sudden cardiac death and malignant ventricular arrhythmias. Subendocardial resection, the automatic internal defibrillator, or both.Q54352257
Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery diseaseQ67898638
The role of beta-blockade therapy for ventricular tachycardia induced with isoproterenol: a prospective analysisQ68162787
Prognosis of patients with ventricular tachycardia or fibrillation and a normal electrophysiologic studyQ68178081
Significant variability in the mode of ventricular tachycardia induction and its implications for interpretation of acute drug testingQ68497952
Determinants of prognosis in symptomatic ventricular tachycardia or ventricular fibrillation late after myocardial infarction. The Dutch Ventricular Tachycardia Study Group of the Interuniversity Cardiology Institute of The NetherlandsQ68534982
Effect of empiric antiarrhythmic therapy in resuscitated out-of-hospital cardiac arrest victims with coronary artery diseaseQ68779133
Day-to-day reproducibility of antiarrhythmic drug trials using programmed extrastimulus techniques for ventricular tachyarrhythmias associated with coronary artery diseaseQ68918905
The natural history of benign and potentially malignant ventricular arrhythmias with special reference to nonsustained ventricular tachycardiaQ69043867
The wide QRS tachycardiaQ69051628
A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoringQ69062283
The current status of ablation of cardiac conduction tissue and ectopic myocardial foci by transvenous electrical dischargesQ69543562
Comparison of the efficacy of propranolol and amiodarone in suppressing ventricular arrhythmias following myocardial infarctionQ69562817
Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart diseaseQ69598112
Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillationQ69639939
The value of the clinical history to assess prognosis of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarctionQ69749308
Electrophysiologic effects of epinephrine in humansQ69826160
The role of beta blocking agents as adjunct therapy to membrane stabilizing drugs in malignant ventricular arrhythmiaQ69881361
Determinants of prognosis in ventricular tachyarrhythmia patients without induced sustained arrhythmiasQ70023982
The arrhythmogenicity of antiarrhythmic agentsQ70101290
Reduction of complex ventricular arrhythmias after enalapril treatment in patients with advanced stable heart failureQ70198711
Effects of oral digoxin on ventricular ectopy and its relation to left ventricular functionQ70243860
Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapyQ71512942
Holter versus electrophysiologic studies in the management of malignant ventricular arrhythmiasQ71722022
Determinants of survival in patients with ventricular tachyarrhythmiasQ71747036
Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugsQ72664804
P433issue800
P407language of work or nameEnglishQ1860
P921main subjectventricular tachycardiaQ56002
P304page(s)406-414
P577publication date1992-06-01
P1433published inPostgraduate Medical JournalQ7234294
P1476titleDiagnosis and management of ventricular tachycardia
P478volume68

Reverse relations

cites work (P2860)
Q43240443Diagnosis and management of ventricular tachycardia
Q42611996Sustained ventricular tachycardia in the emergency department

Search more.